All Pathways
PediatricsEmergency

Neonatal Hypoglycemia (PES 2015)

Neonatal Hypoglycemia (PES 2015): Neonatal Hypoglycemia Risk Assessment → Risk Factors for Neonatal Hypoglycemia → Treatment Thresholds → Symptomatic? →...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Neonatal Hypoglycemia Risk Assessment

    Identify at-risk newborns

    1. Action

      Risk Factors for Neonatal Hypoglycemia

      Screen high-risk infants

      • HIGH RISK:
      • • Infant of diabetic mother (IDM)
      • • Large for gestational age (LGA)
      • • Small for gestational age (SGA)
      • • Preterm (<37 weeks)
      • • Perinatal stress (asphyxia, sepsis, hypothermia)
      • • Maternal beta-blockers, sulfonylureas
      • Screen glucose at 30-60 min of age if risk factors
      1. Action

        Treatment Thresholds

        When to treat (varies by guideline)

        • COMMON THRESHOLDS:
        • • <25 mg/dL (<1.4 mmol/L): Always treat
        • • 25-40 mg/dL: Treat if symptomatic, feed if asymptomatic
        • • <45-50 mg/dL after 4-24 hrs: Consider treatment
        • AAP: <25 mg/dL in first 4h, <35 mg/dL at 4-24h
        • PES: <50 mg/dL if symptomatic
        • GOAL: Maintain ≥45-50 mg/dL
        1. Decision

          Symptomatic?

          Assess for symptoms of hypoglycemia

          • SYMPTOMS:
          • • Jitteriness, tremors
          • • Lethargy, hypotonia
          • • Poor feeding, weak cry
          • • Hypothermia
          • • Seizures, apnea
          • • Cyanosis
          1. Action

            Asymptomatic - Oral Feeding Trial

            Feed and recheck

            • Initiate feeding (breast or formula)
            • Feed 10-15 mL/kg
            • Recheck glucose 30-60 min after feed
            • If still low after feed:
            • • May give 40% dextrose gel 0.5 mL/kg buccal
            • • Recheck in 30 min
            • • If still low → IV dextrose
            1. Decision

              Glucose Normalizing?

              Monitor response to treatment

              1. Action

                Wean IV Glucose

                Transition to enteral feeding

                • Wean GIR by 1-2 mg/kg/min q3-6h
                • Increase enteral feeds simultaneously
                • Monitor pre-feed glucose
                • Discontinue IV when:
                • • Taking full enteral feeds
                • • Pre-feed glucose ≥50 mg/dL consistently
              2. Action

                Increase GIR

                Persistent hypoglycemia

                • Increase GIR by 2 mg/kg/min increments
                • May need GIR 10-15+ mg/kg/min
                • If requiring GIR >12 mg/kg/min:
                • • Consider hyperinsulinism
                • • Send critical sample before correction:
                • - Insulin, cortisol, GH, free fatty acids
                • - Beta-hydroxybutyrate, lactate, ammonia
                • Consult endocrinology if persistent
                1. Warning

                  Persistent Hypoglycemia Workup

                  If hypoglycemia persists >48-72h

                  • CONSIDER:
                  • • Hyperinsulinism (most common)
                  • • Hypopituitarism
                  • • Cortisol deficiency
                  • • Fatty acid oxidation defects
                  • • Glycogen storage disease
                  • Send critical sample during hypoglycemia
                  • MRI brain if hypopituitarism suspected
                  • Genetic testing may be indicated
          2. Action

            Symptomatic or Severe - IV Dextrose

            Immediate IV treatment

            • IV BOLUS:
            • D10W 2 mL/kg (200 mg/kg) over 5-10 min
            • THEN INFUSION:
            • D10W at glucose infusion rate (GIR) 5-8 mg/kg/min
            • GIR calculation:
            • GIR = (rate mL/kg/day × dextrose %) / 144
            • Recheck glucose q30-60 min
            • Titrate to maintain ≥50 mg/dL

Guideline Source

Pediatric Endocrine Society Recommendations for Evaluation and Management of Persistent Hypoglycemia 2015

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Threshold definitions vary by institution
  • Does not address hyperinsulinism workup in detail
  • Premature infant thresholds may differ

Applicable Regions

USEU
Version 1Next review: 2027-01-11

Frequently Asked Questions

What is the Neonatal Hypoglycemia (PES 2015)?

The Neonatal Hypoglycemia (PES 2015) is a emergency clinical algorithm for Pediatrics. It provides a structured decision tree to guide clinical decision-making, based on Pediatric Endocrine Society Recommendations for Evaluation and Management of Persistent Hypoglycemia 2015.

What guideline is the Neonatal Hypoglycemia (PES 2015) based on?

This algorithm is based on Pediatric Endocrine Society Recommendations for Evaluation and Management of Persistent Hypoglycemia 2015 (DOI: 10.1016/j.jpeds.2015.03.057).

What are the limitations of the Neonatal Hypoglycemia (PES 2015)?

Known limitations include: Threshold definitions vary by institution; Does not address hyperinsulinism workup in detail; Premature infant thresholds may differ. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Neonatal Hypoglycemia (PES 2015) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free